课题基金 / 基金详情

ID OF A SITE IN MEF2D THAT IS MODIFIED BY O-LINKED N-ACETYLGLUCOSAMINE

ID OF A SITE IN MEF2D THAT IS MODIFIED BY O-LINKED N-ACETYLGLUCOSAMINE
MEF2D 中被 O-连接的 N-乙酰葡萄糖胺修饰的位点的 ID
批准号:
7957416
负责人:
Eric M. Verdin
金额:
$0.01万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2010-05-31

项目摘要

项目成果

Eric M. Verdin的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Mef2D (Myocyte enhancer binding factor 2D) belongs to a family of four transcription factor namely Mef2A, Mef2B, Mef2C and Mef2D. This family of transcription factor shares a highly conserved MADS (MCM1, Agamous, Deficiens, SRF) domain, as well as a unique MEF2 domain. These two domains together constitute the N-terminal 87 amino acids of the MEF2 transcription factors, and mediate DNA binding, dimerization, and interaction with multiple coactivators and corepressors. The C-terminal domain of this family is more divergent and contains the transcriptional activation domain (TAD). The activity of Mef2D is regulated by multiple post-translational modifications. Mef2D is known to be phosphorylated, acetylated and sumoylated. A relatively newly identified modification, O-linked N-acetyl glucosamine (O-GlcNAc), is an abundant post-translational modification that modulates function of several phospho-proteins with diverse cellular functions. O-GlcNAc modifies serines and threonines of nuclear and cytoplasmic proteins and the modified proteins have important function in protein-protein interaction, transcription and signal transduction. O-GlcNAc exists in a complex interplay with phosphorylation and in many cases phosphorylation has been found to be reciprocal to O-GlcNAc. Our studies, using antibody against O-GlcNAc, show that Mef2D is modified by O-GlcNAc. To understand the function of Mef2D glycosylation, we need to identify the site of modification. Identification of the site will allow us to mutate the site and perform further analysis. The UCSF Mass Spectrometry Facility will help us with this part of the project to identify the site of O-GlcNAc and also help us identify if the same site is also modified by phosphorylation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
Molecular Mechanisms of HIV Latency
海外基金